🔥 biotech 핫 테마 분석

S-Class [MRNA] Moderna shorts reportedly suffer $5B loss after stock’s sudden rise

S-Class [TWST] Twist Bio jumps sending AI-linked peers higher after Anthropic announcement

S-Class [MRNA] Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock is soaring.

The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.

S-Class [MRNA] Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock more than doubles

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

S-Class [MRNA] Healthcare ETFs rally as Moderna nearly doubles on melanoma win

S-Class [MRNA] Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

S-Class [MRNA] Moderna shares soar over 100% on melanoma drug trial success